 |
TREATMENTS IN THE PIPELINE: 150 headlines |
|
|||||
My Educational Video on MS and MS Trials| Visitors Since 03/2006 |
||||||||||||||||||||||||||||||||||||||
| Our 670 MySpace Friends The New Face of MS |
||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
 Click to view 1280 MS Walk photos! | ||||||||||||||||||||||||||||||||||||||
| "Join a trial at Barrow & receive all medication & study based procedures at no charge!" | ||||||||||||||||||||||||||||||||||||||
Stan Swartz, CEO, The MD Health Channel "WE PRODUCED THE FOLLOWING 9 VIDEOS FOR YOU!" Simply click the "video" buttons below: . |
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
| Previious Posts | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
| MS NEWS ARCHIVES: by week | ||||||||||||||||||||||||||||||||||||||
| June 2006 | ||||||||||||||||||||||||||||||||||||||
| July 2006 | ||||||||||||||||||||||||||||||||||||||
| August 2006 | ||||||||||||||||||||||||||||||||||||||
| September 2006 | ||||||||||||||||||||||||||||||||||||||
| October 2006 | ||||||||||||||||||||||||||||||||||||||
| November 2006 | ||||||||||||||||||||||||||||||||||||||
Saturday
NEW MS DRUG IN PIPELINE: STANFORD UNIVERSITY APPLIES FOR PATENT
"Method of treating rheumatoid arthritis and MS ...: "Applicant The Board of Trustees of the Leland Stanford Junior University...Inventor(s) Godfrey, Wayne
Engleman, Edgar G.....Abstract The invention provides ligands and fragments
thereof to a receptor on the surface of activated CD4+T-cells. An
exemplary ligand is designated ACT-4-L-h-1. Preferred fragments include
purified extracellular domains of ligands. The invention also provides
humanized and human antibodies to the ligand. The invention further provides
methods of using the ligand and the antibodies in treatment of diseases and
conditions of the immune system. The invention also provides methods of
monitoring activated CD4+T-cells using the ligands or fragments
thereof. If you would like to purchase a copy of this patent, please call MicroPatent at 800-648-6787."
"Method of treating rheumatoid arthritis and MS ...: "Applicant The Board of Trustees of the Leland Stanford Junior University...Inventor(s) Godfrey, Wayne
Engleman, Edgar G.....Abstract The invention provides ligands and fragments
thereof to a receptor on the surface of activated CD4+T-cells. An
exemplary ligand is designated ACT-4-L-h-1. Preferred fragments include
purified extracellular domains of ligands. The invention also provides
humanized and human antibodies to the ligand. The invention further provides
methods of using the ligand and the antibodies in treatment of diseases and
conditions of the immune system. The invention also provides methods of
monitoring activated CD4+T-cells using the ligands or fragments
thereof. If you would like to purchase a copy of this patent, please call MicroPatent at 800-648-6787."